A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above

Clinical trial NCT06361875 · COMPLETED

Trial details

NCT number: NCT06361875
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Influenza Immunization Healthy Volunteers

Start date: 2024-04-01
Primary completion: 2025-06-09
Enrollment: 908

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.